KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Mark R Warner (Senate) disclosed 2 transactions

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

2020-11-16 · sellEB 480 Sprague, LLC Company: EB 480 Sprague, LLC (Dedham, MA) Description: Real Estate — $1,000,001 - $5,000,000
2020-11-20 · buyAcumen Pharmaceuticals, Inc. Company: Acumen Pharmaceuticals, Inc. (South San Francisco, CA) Description: Drug Discovery — $50,001 - $100,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerSelf
partyDemocrat
stateVA
officeWarner, Mark R (Senator)
ptr id8a358a66-5b4a-45b3-80af-97cfb2256d97
ticker—
chambersenate
report urlhttps://efdsearch.senate.gov/search/view/ptr/8a358a66-5b4a-45b3-80af-97cfb2256d97/
bioguide idW000805
data sourceSENATE_EFD_PTR
member lastWarner
member nameMark R Warner
member firstMark R
state district—
disclosure date2020-12-09
amendment statusoriginal
transaction natureOPEN_MARKET

Each transaction (2)

idcommentamount maxamount minasset nameasset typeamount rangetransaction datetransaction typereporting lag days
senate-8a358a66-5b4a-45b3-80af-97cfb2256d97-2Underlying asset of Echo Bridge Realty Fund, I L.P.50000001000001EB 480 Sprague, LLC Company: EB 480 Sprague, LLC (Dedham, MA) Description: Real EstateOther$1,000,001 - $5,000,0002020-11-16sell16
senate-8a358a66-5b4a-45b3-80af-97cfb2256d97-1--10000050001Acumen Pharmaceuticals, Inc. Company: Acumen Pharmaceuticals, Inc. (South San Francisco, CA) Description: Drug DiscoveryNon-Public Stock$50,001 - $100,0002020-11-20buy13

Original filing document